The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Pneumonia Childhood

Interventions

DRUG

Melatonin

1 mg/dose in infants and 2.5 to 3mg/dose in children three times a day for 14 days

Trial Locations (1)

RECRUITING

Pakistan Institute of Medical Sciences, Islamabad

All Listed Sponsors

lead

Mian Muhammad Hassan Ahmed

OTHER

NCT06949904 - The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia | Biotech Hunter | Biotech Hunter